APVO101

recombinant factor IX · Medexus Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APVO101, covering 2024-05-16 to 2024-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B [Phase 3]

See pricing